XENE Xenon Pharmaceuticals
- 42.630
- -0.520-1.21%
- 42.630
- 0.0000.00%
Xenon Pharmaceuticals News
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PATOU GARY
Xenon Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Xenon Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Xenon Pharmaceuticals | 8-K: Current report
Xenon Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(9.064%),Abigail P. Johnson(9.064%)
Xenon Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Xenon Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Xenon Pharmaceuticals | 8-K: Current report
Xenon Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Xenon Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PATOU GARY
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Machado Patrick
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gover Justin D.
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GAROFALO ELIZABETH A.
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GANNON STEVEN
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Cannon Gillian
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Svoronos Dawn
Xenon Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Xenon Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Xenon Pharmaceuticals | 8-K: Current report
Analysis
Price Target
No Data
No Data